Skip to main content

Find Clinical Trials

Home
Conditions
Pulmonary Fibrosis

Clinical trial condition

Pulmonary Fibrosis

Explore clinical trials studying Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

380 public trials 55 recruiting studies

Refine in advanced search Browse all conditions

Pulmonary Fibrosis trial results

Recruiting

Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)

NCT00373841

Conditions: Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations: Michelle F MacPherson Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Photon-counting CT Scan vs Standard HRCT Scan in the Identification of Idiopathic Pulmonary Fibrosis

NCT07790614

Conditions: CT, CT Photon-Counting, CT Scan, +11 more
Locations: Humanitas Research Hospital Rozzano, Italy

View Trial Details

Recruiting

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.

NCT06267183

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: Shanghai Xuhui District Central Hospital Shanghai, China

View Trial Details

Recruiting

Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis

NCT04362644

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: The University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Recruiting

Emotional and Social Experiences of Antifibrotic (AF) Therapy Among Idiopathic Pulmonary Fibrosis (IPF)/Progressive Pulmonary Fibrosis (PPF) Patients: A Real-World Study

NCT07743996

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +3 more
Locations: Nippon Boehringer Ingelheim Co., Ltd. Tokyo, Japan

View Trial Details

Recruiting

Dose-Escalation Study of Artesunate Patients With IPF

NCT05988463

Conditions: Cough, Dyspnea, Fibrosis, +11 more
Locations: Stanford University Stanford, California, United States

View Trial Details

Recruiting

AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF

NCT07194382

Conditions: Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations: Nepean Lung and Sleep Kingswood, New South Wales, Australia

Dynamic Drug Advancement Ajax, Ontario, Canada

CIC Mauricie Trois-Rivières, Quebec, Canada

Royal Prince Alfred Hospital Camperdown, New South Wales, Australia

View all 24 locations

View Trial Details

Recruiting

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT06967805

Conditions: Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations: WISPer Site in Birmingham, AL Birmingham, Alabama, United States

WISPer site in Phoenix, AZ Phoenix, Arizona, United States

WISPer Site in Los Angeles, CA Los Angeles, California, United States

WISPer site in Newport Beach, CA Newport Beach, California, United States

View all 71 locations

View Trial Details

Recruiting

Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease

NCT07723872

Conditions: Connective Tissue Disease-associated Interstitial Lung Disease, Connective Tissue Diseases, Idiopathic Pulmonary Fibrosis, +11 more
Locations: Hospital de Granollers Granollers, Spain

View Trial Details

Recruiting

Identification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Pulmonary Neoplasia

NCT07707245

Conditions: COPD, Chronic Disease, Disease Attributes, +16 more
Locations: IRCCS Fondazione Don Carlo Gnocchi Milan, Italy

View Trial Details